GENFIT Stock Börse Stuttgart
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Börse Stuttgart
23:55:42 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.48 EUR | -1.54% |
|
-11.15% | +125.10% |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 09-15 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
| Market Cap | 578M 663M 546M 496M 929M 63.63B 933M 6.54B 2.52B 32.35B 2.49B 2.44B 104B | P/E 2026 * |
29.8x | P/E 2027 * | 65.9x |
|---|---|---|---|---|---|
| Enterprise Value | 527M 605M 498M 452M 847M 58.01B 850M 5.96B 2.3B 29.49B 2.27B 2.22B 94.9B | EV / Sales 2026 * |
5.26x | EV / Sales 2027 * | 4.02x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| GNFT | Real-time | |
CBOE
| GNFTp | Real-time | |
|
Börse Stuttgart
| XUP | Delayed | |
|
Xetra
| XUP | Delayed | |
|
OTC Markets
| GNFTF | Delayed | |
|
Tradegate
| XUP | Real-time | |
|
Boerse Muenchen
| XUP | Real-time | |
|
Deutsche Boerse AG
| XUP | Delayed | |
|
London S.E.
| 0QT6 | Delayed | |
|
CBOE
| 0QT6 | Real-time |
Last Transcript: GENFIT
| 1 day | -1.54% | ||
| 1 week | -11.15% | ||
| Current month | -18.00% | ||
| 1 month | -19.72% | ||
| 3 months | +7.09% | ||
| 6 months | +26.08% | ||
| Current year | +125.10% |
| 1 week | 11.46 |  | 13.1 |
| 1 month | 11.46 | | 14.8 |
| Current year | 5.06 | | 15.4 |
| 1 year | 3.58 | | 15.4 |
| 3 years | 3.3 | | 15.4 |
| 5 years | 2.96 | | 15.4 |
| 10 years | 2.96 | | 21.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54% | -11.15% | - | - | 663M | |
| +0.11% | +2.71% | +0.44% | +26.85% | 46.28B | |
| -1.12% | +1.78% | +42.30% | +27.55% | 43.85B | |
| -3.04% | -6.29% | +338.56% | +515.97% | 40.93B | |
| -0.74% | +1.25% | +4.92% | +67.98% | 39.89B | |
| -0.50% | +0.67% | +10.29% | +41.28% | 29.5B | |
| -0.46% | +4.22% | +22.81% | +139.44% | 17.09B | |
| -0.97% | -10.17% | - | - | 15.55B | |
| -0.57% | +8.12% | +22.19% | +38.68% | 15.22B | |
| -3.14% | +31.91% | -11.79% | - | 14.05B | |
| Average | -1.20% | +3.76% | +53.72% | +122.54% | 29.15B | |
| Weighted average by Cap. | -1.10% | +1.87% | +68.04% | +130.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 115M 94.69M 85.99M 161M 11.04B 162M 1.13B 438M 5.61B 432M 422M 18.05B | 127M 146M 120M 109M 204M 13.98B 205M 1.44B 554M 7.11B 547M 535M 22.86B |
| Net income | 22.88M 26.24M 21.6M 19.62M 36.75M 2.52B 36.91M 259M 99.86M 1.28B 98.56M 96.37M 4.12B | 9.07M 10.4M 8.56M 7.77M 14.57M 998M 14.63M 103M 39.57M 507M 39.06M 38.19M 1.63B |
| Net Debt | -51.11M -58.61M -48.26M -43.82M -82.1M -5.62B -82.44M -578M -223M -2.86B -220M -215M -9.2B | -67.56M -77.48M -63.79M -57.93M -109M -7.43B -109M -764M -295M -3.78B -291M -285M -12.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | €11.48 | -1.54% | 9,695 |
| 17/09/26 | €11.66 | -2.02% | 2,145 |
| 16/09/26 | €11.90 | +1.54% | 14,205 |
| 15/09/26 | €11.72 | -5.64% | 7,263 |
| 14/09/26 | €12.42 | -3.87% | 5,748 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
